CHM needed funding and now has funding. The carry on about being diluted when the retail shareholders didn’t subscribe full amount in previous raises is hilarious. At this end of the market, risk is high. Way more important to have funding available to continue progressing pipeline than to be in administration
Ann: $6.6 million Placement to advance clinical trial pipeline, page-52
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(16.7%) |
Mkt cap ! $11.37M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $2.689K | 768.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 76 | 70899139 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 83645026 | 25 |
View Market Depth
| Last trade - 10.53am 01/08/2025 (20 minute delay) ? |
| CHM (ASX) Chart |